| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
SPECIAL SECTION ON SYSTEMS BIOLOGY OF THE MITOCHONDRION
Divisions of 1Cardiology, 2Clinical Pharmacology, and 3Pharmacology, Department of Medicine, Case Western Reserve University and Medical Service, 4Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio; Departments of 5Anesthesiology and 6Physiology, 7Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee; 8Zablocki Veterans Affairs Medical Center, Milwaukee; and 9Department of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin
Submitted 16 May 2006 ; accepted in final form 7 September 2006
 |
ABSTRACT |
|---|
 TOP ABSTRACT MITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
cardiolipin; cytochrome c; complex I; cytochrome oxidase
|
MITOCHONDRIA AS TARGETS OF DAMAGE DURING ISCHEMIA |
|---|
|
TOPABSTRACTMITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
Cardiac mitochondria exist in two functionally distinct populations, subsarcolemmal mitochondria (SSM) that reside beneath the plasma membrane and interfibrillar mitochondria (IFM) located between the myofibrils (87, 107). SSM have a decreased capacity for calcium accumulation compared with IFM (108). Calcium loading in SSM led to the release of cytochrome c, whereas a similar extent of calcium loading in IFM did not result in cytochrome c release, even when the capacity of IFM to retain calcium was exceeded (108). Thus SSM are more susceptible to calcium overload-mediated cytochrome c release and mitochondrial damage compared with IFM (108). Progression of ischemic damage is more rapid in SSM than in IFM (45, 69, 90, 126, 140).
Complex I activity decreases during ischemia due to a decrease in the NADH dehydrogenase component (104, 120), likely due to the loss of the flavin mononucleotide coenzyme (120). Damage to the NADH dehydrogenase component of complex I can increase electron leak and the production of ROS (139). Complex I activity is also modulated by posttranslational modifications, including S-nitrosylation (22) and phosphorylation (31). Ischemia damages complex III by functional inactivation of the iron-sulfur protein (ISP) subunit (83). The 22 kDa ISP contains a 2 Fe-2 S redox-active iron-sulfur cluster. Ischemic damage to the iron-sulfur protein decreases the intensity of the electron paramagnetic resonance signal of the iron-sulfur cluster without the loss of the ISP peptide, suggesting that ischemia disrupts the cluster without degradation of the ISP subunit (83). Cytochrome oxidase, composed of 13 peptide subunits, requires the integrity of catalytic subunits (13) and of regulatory and structural subunits (8), as well as an intact inner mitochondrial membrane environment enriched in the phospholipid cardiolipin for optimal activity (119, 144). Ischemia does not lead to the functional inactivation of a subunit peptide (90). Decreased respiration through cytochrome oxidase occurs due to a selective decrease in cardiolipin content (89).
|
MITOCHONDRIA AS SOURCES OF CARDIAC INJURY DURING ISCHEMIA |
|---|
|
TOPABSTRACTMITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
Mitochondria are a primary source for ROS production during ischemia (15, 39, 142). Superoxide production during simulated ischemia in cardiac myocytes is decreased by blockade of electron transfer into complex III (15, 142). In contrast, antimycin A blockade distal within complex III or inhibition of cytochrome oxidase increased ROS generation (15). These observations are in line with complex III as the dominant site for extra mitochondrial release of ROS (30, 59). Complex III is emerging as the major site for the production of ROS that are detected within the cardiomyocyte during ischemia.
Ischemia leads to release of cytochrome c from mitochondria. Cytochrome c content decreases in SSM at 30 min of ischemia, concomitant with cardiolipin loss (89, 90). Cardiolipin interacts with cytochrome c via nonionic (121, 122, 128) and electrostatic (106) mechanisms that localize cytochrome c at the inner membrane (106). Cardiolipin depletion delocalizes cytochrome c from the inner membrane (106, 125), the first step in cytochrome c release from mitochondria (106). A subsequent increase in permeability of the mitochondrial outer membrane then allows the loss of delocalized cytochrome c (106). Outer membrane permeability increases due to disruption of the outer membrane lipid bilayer, as a result of the activation of cytosolic and perhaps mitochondrial phospholipases (50), or the insertion of proapoptotic peptides into the mitochondrial outer membrane (73).
Cytochrome c release into cytosol occurs during ischemia in isolated rat and rabbit hearts (18, 20, 21, 89, 90). Release of cytochrome c during ischemia activates downstream caspase 3 leading to an increase in the number of cardiomyocytes displaying apoptotic markers (21) that becomes increasingly evident during reperfusion (21, 25, 53, 63). In the isolated perfused rabbit heart, the decrease in mitochondrial cytochrome c content occurs during ischemia, without additional decreases during reperfusion (81). Thus injury to mitochondria during ischemia is sufficient to release cytochrome c for activation of apoptotic pathways.
|
BLOCKADE OF ELECTRON TRANSPORT PROTECTS MITOCHONDRIA AND DECREASES ROS PRODUCTION DURING ISCHEMIA |
|---|
|
TOPABSTRACTMITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
To address this proposed scheme during in situ ischemia in the intact heart, the ETC was inhibited with rotenone, an irreversible inhibitor of complex I. The contents of cardiolipin, cytochrome c, and the rate of oxidation through cytochrome oxidase were measured after 45 min of global ischemia in the isolated rabbit heart (80). In untreated controls, ischemia decreased the contents of cardiolipin and cytochrome c, and decreased respiration through cytochrome oxidase as described above. In the presence of rotenone-mediated blockade of electron transport, cardiolipin content was preserved in SSM even after 45 min of ischemia (80) (Fig. 1). Rotenone treatment favored the retention of cytochrome c by SSM (80) (Fig. 1). ADP-stimulated respiration through cytochrome oxidase in SSM was higher in rotenone-treated hearts (Fig. 1). Thus, blockade of the proximal ETC with rotenone, a high-affinity and irreversible inhibitor of complex I, markedly attenuated ischemic damage to cardiolipin, cytochrome c, and cytochrome oxidase, even following a relatively prolonged period of 45 min. On the basis of the critical role of cardiolipin in retaining cytochrome c within the mitochondria, it is not surprising that preservation of cardiolipin content during ischemia by rotenone treatment led to preserved cytochrome c content. Thus ischemic damage to mitochondria is mediated by the mitochondria themselves (80). Limitation of electron flow during ischemia is a new concept to limit mitochondrial damage during ischemia. Although the irreversible inhibitor rotenone was useful to test experimentally this concept, a reversible inhibitor of electron transport was required to carry the concept forward into reperfusion. In this way, the relationship between preservation of the ETC during ischemia and the reduction of myocardial injury after ischemia and reperfusion could be tested.
|
5 mM, amobarbital also inhibits succinate respiration and complex V (24). Inhibition of respiration through complex I by amobarbital is rapidly reversible (127). Amobarbital treatment of the isolated rat heart immediately before ischemia protects oxidative phosphorylation and preserves cytochrome c content in SSM and IFM during ischemia (26). This protection is concentration dependent with 2–2.5 mM providing the optimal range (26). These concentrations are consistent with those previously found to selectively inhibit complex I (61). Amobarbital treatment also preserves oxidative phosphorylation through cytochrome oxidase, previously observed with rotenone treatment. Respiration with glutamate, a complex I substrate, is also preserved (26) (Fig. 2). Thus, amobarbital must have washed out of the mitochondria during the isolation process, confirming the rapidly reversible nature of inhibition. Amobarbital avidly binds to albumin (24), and the use of isolation buffers containing bovine serum albumin during mitochondrial isolation (46, 107) favors the redistribution of amobarbital out of the mitochondria. In contrast, when rotenone was administered to the heart, glutamate respiration in isolated mitochondria was blocked (80). These findings indicate that amobarbital treatment immediately before ischemia leads to a reversible inhibition of respiration, in line with previous findings in isolated mitochondria (127) and in the isolated heart (4, 110).
|
Studies at the level of the intact heart provide additional support for the specificity of amobarbital treatment and provide insights into mechanisms of protection (2, 3). Isolated buffer-perfused guinea pig hearts were treated with either 2.5 mM amobarbital or vehicle for 1 min immediately before 30 min of ischemia, followed by 60 min of reperfusion. Mitochondrial NADH, FAD, calcium, and intracellular ROS were measured by fluorescence spectrophotometry with a fiber optic probe placed at the left ventricular free wall. Tissue autofluorescence was used to measure NADH and FAD (5–7, 115, 116, 118, 129). Mitochondrial Ca2+ concentration was measured in indo 1-AM-loaded hearts after quenching cytosolic Ca2+ with MnCl2 (116, 117, 129). ROS, primarily superoxide, was monitored in dihydroethidium (DHE) loaded hearts (23, 71, 116, 129, 146) by measuring the fluorescence of a DHE intermediate that results primarily from the reaction with superoxide (
ex, 540 nm; em, 590 nm) (146). NADH increased in both groups during early ischemia; during late ischemia, NADH declined in the vehicle group but remained elevated in the amobarbital group, consistent with in situ inhibition of complex I (Fig. 3). During late ischemia, DHE fluorescence was higher in the vehicle group than in the amobarbital group, supporting a decrease in the previously observed ROS generation during ischemia in this model (71) by blockade of electron transport with amobarbital (2, 3). Mitochondrial Ca2+ loading during ischemia was attenuated in the amobarbital-treated hearts compared with vehicle controls. Thus blockade of electron transport during ischemia preserves respiratory function in isolated mitochondria (26) accompanied by decreased production of ROS and reduced Ca2+ accumulation as evident in the intact heart (2, 3). Protection of mitochondria by blockade of electron transport at the rotenone site of complex I localizes the site of ROS production distal to complex I, most likely at complex III.
|
|
IMPROVED MITOCHONDRIAL FUNCTION DURING ISCHEMIA PRESERVES MITOCHONDRIAL FUNCTION AND DECREASES CARDIAC INJURY ON REPERFUSION |
|---|
|
TOPABSTRACTMITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
|
The role of ischemic mitochondrial damage in myocardial injury was then addressed. Reperfusion of myocardium with reduced ischemic damage to the ETC led to improved contractile recovery, decreased marker enzyme release, and decreased infarct size following reperfusion in the isolated perfused rat heart (28) (Fig. 4). Treatment of isolated guinea pig hearts with amobarbital just before 30 min of ischemia resulted in a 87 ± 5% higher left ventricular developed pressure at 60 min of reperfusion and a 33 ± 7% smaller infarct size compared with the vehicle control group (2). Thus reperfusion of the heart in the setting of preserved mitochondrial function improved contractile recovery and decreased infarct size. The reduction of ischemic damage to cardiac mitochondria preserves mitochondrial function during reperfusion and decreases myocardial injury.
The preservation of mitochondrial function during ischemia and reperfusion by blockade of electron transport attenuates cardiac injury during reperfusion by at least two potential mechanisms. First, the capacity of cardiac mitochondria to release H2O2 during reperfusion is substantially attenuated when oxidative phosphorylation is preserved by amobarbital treatment (27) (Fig. 4). Protection of the ETC chain during ischemia by amobarbital markedly decreased net H2O2 production with both complex I and complex II substrates in isolated SSM and IFM compared with those from vehicle-treated control hearts (27). The decrease in H2O2 production with succinate as substrate in the presence of rotenone to block reverse electron flow indicates that protection of mitochondria decreases ROS production most likely from complex III. Thus preservation of respiratory function decreases mitochondrial production and release of ROS during reperfusion.
Second, blockade of electron transport during ischemia enhanced the retention of cytochrome c by cardiac mitochondria following reperfusion. Amobarbital treatment decreased state 4 respiratory rates after ischemia and reperfusion, an indicator of decreased damage to the mitochondrial inner membrane (28), protection that favors the retention of cytochrome c (89, 106). Normally the outer mitochondrial membrane is impermeable to cytochrome c (18, 145). Delocalized cytochrome c is released from mitochondria when outer-membrane permeability increases (106, 145). Blockade of electron transport during ischemia preserved outer-membrane integrity measured after reperfusion (28), unlike the increased outer-membrane permeability present in mitochondria from vehicle-treated hearts. Preserved outer-membrane integrity also favors the retention of cytochrome c by mitochondria. The mechanism leading to preserved outer-membrane integrity achieved by the reversible blockade of electron transport during ischemia is the subject of ongoing work.
The cardiac protection observed when the heart is reperfused in the setting of preserved mitochondrial function provides strong support for the working hypothesis that ischemic damage to mitochondria is a key mechanism of myocardial injury during reperfusion. Blockade of electron transport during ischemia has provided a mechanistic link regarding the key role of mitochondrial damage during ischemia in the genesis of cardiac injury during reperfusion.
|
MODULATION OF MITOCHONDRIAL FUNCTION DURING REPERFUSION PROTECTS AGAINST CONSEQUENCES OF ISCHEMIA-INDUCED MITOCHONDRIAL DAMAGE |
|---|
|
TOPABSTRACTMITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
Pioneering studies by Ganote and colleagues (51, 52) showed that inhibition of mitochondrial respiration can decrease contraction band formation and attenuate enzyme release during reoxygenation, suggesting that resumption of mitochondrial metabolism during reoxygenation can initially lead to deleterious consequences. Reperfusion-induced declines in cardiac function and the accumulation of oxidatively damaged lipids are diminished when mitochondrial respiration was reversibly inhibited during early reperfusion using amobarbital (4), underlining the physiologic significance of mitochondrial ROS production during reperfusion to cardiac injury during reperfusion. In contrast, inhibition of cytochrome oxidase did not confer protection (4). The observed decrease in ROS production and improved myocardial protection when amobarbital was given during reperfusion strongly suggest that the site of ROS production is distal to the site of amobarbital block and proximal to cytochrome oxidase, namely complex III.
Mitochondrial permeability transition (MPT) appears to contribute to myocardial injury during ischemia (21) and especially during reperfusion (36). A component of MPT observed in situ in the heart likely occurs secondary to transient, reversible opening of the transition pore (145). Increased calcium availability during reperfusion enhances mitochondrial calcium loading (11, 55, 57). Enhanced mitochondrial oxidative damage and calcium loading predispose to the onset of MPT during reperfusion (36, 145). On the basis of their greater sensitivity to calcium-mediated damage (108), MPT during reperfusion may largely involve SSM. MPT appears to be reversible during reperfusion, with closure of the permeability transition pore enhanced by pyruvate oxidation during early reperfusion (35, 37, 58, 145). Inhibitors of MPT decrease myocardial damage during ischemia and reperfusion (36, 43, 54). Protection of mitochondrial function during ischemia by reversible inhibition of electron transport (26) led to decreased ROS production and mitochondrial calcium loading during reperfusion (2), which would be expected to decrease the probability of opening of permeability transition pore during reperfusion.
Pharmacological inhibition of mitochondrial respiration during early reperfusion by amobarbital decreases mitochondrial-driven myocardial injury during reperfusion (4). Restriction of oxidative metabolism during early reperfusion using hypoxic reperfusate also attenuates mitochondrial and cardiac damage (111, 124). Transient blockade of mitochondrial oxidative metabolism by the repetitive, brief reinstitution of intermittent stop flow ischemia, postconditioning, decreases cardiac injury (9, 147). Postconditioning decreases the generation of ROS from mitochondria (62, 124, 130). Mitochondrial calcium overload and the probability of MPT are also attenuated (9, 17, 62, 130). Thus a variety of approaches can be used to modulate the aberrant oxidative metabolism of ischemically damaged mitochondria to interrupt the link between ischemic damage to mitochondria and mitochondrial-driven cardiac injury during reperfusion.
|
IPC MODULATES MITOCHONDRIAL FUNCTION BEFORE INDEX ISCHEMIA |
|---|
|
TOPABSTRACTMITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
(70) and PKG (34, 60). These signal transduction networks converge on mitochondria and modulate respiration (34, 136). Modulation of mitochondrial oxidative metabolism before a prolonged ischemic insult is a likely mechanism of cardioprotection. Isolation of cardiac mitochondria following the IPC stimulus, before the index ischemia, decreased mitochondrial oxidative phosphorylation in one study (38), but not another (72). As a consequence of the observation of the robust mitochondrial and myocardial protection observed after blocking electron transport during ischemia, we suggested that the IPC stimulus would decrease complex I activity and attenuate state 3 respiration through complex I as a potential mechanism of cardioprotection. IPC did not decrease state 3 respiration nor complex I activity in SSM or IFM (132). IPC increased state 4 respiration and decreased the respiratory control rate (RCR) in IFM, indicating decreased coupling of respiration, in line with the primary observations of other investigators as discussed below. Thus, protection of IPC does not occur via the relative blockade of electron transport at complex I at the onset of the sustained index ischemia. The potential of complex I to sustain post-translational modification via phosphorylation (123), nitrosylation (19, 22), or glutathionylation (32), with the potential to modulate complex I activity and respiration with complex I substrates was not observed, even when mitochondria were isolated in the presence of phosphatase inhibitors to preserve phosphorylation status (132). Thus, the cardioprotection achieved with pharmacological blockade of electron transport does not overlap with the mechanisms of IPC. The attenuation of electron transport during ischemia represents an alternative approach to cardioprotection when the triggers or effectors of IPC are impaired.
A high mitochondrial membrane potential favors ROS generation. Uncoupling of mitochondrial respiration decreases membrane potential and consequent electron leak, thereby reducing ROS production from the ETC (99). Thus, mild uncoupling of mitochondrial respiration may lead to cardiac protection. Opening of mitochondrial ATP-sensitive K+ (KATP) channel (34, 44) either by IPC or by pharmacological treatment decreases cardiac ischemia and reperfusion injury (56). The mitochondrial KATP channel is located in the inner membrane, and opening of mitochondrial KATP channels may lead to mild uncoupling (34, 74, 103). However, experimental results remain inconsistent regarding the uncoupling effect of mitochondrial KATP channel opening (105). IPC does, however, decrease ROS during simulated ischemia in cardiac myocytes (141) and during the index global ischemia in the isolated heart (71), most likely as a consequence of the uncoupling of respiration. IPC leads to the uncoupling of respiration observed in isolated mitochondria (103). Interestingly, overexpression of uncoupling protein 2, located in the mitochondrial inner membrane, protects cardiac myocytes against ischemia and reperfusion injury by reducing ROS generation and decreasing mitochondrial Ca2+ overload (135). Dinitrophenol, a chemical uncoupler of respiration protects isolated heart against ischemia and reperfusion injury when given immediately before ischemia (66, 98). Uncoupling of respiration allows the dissipation of membrane potential and circumvents the accumulation of reducing equivalents at cytochrome b of complex III (41, 42) and perhaps the iron-sulfur centers of complex I (76). The presence of reducing equivalents at these redox centers favors "electron leak" to form ROS from complex III (41, 42) and complex I (76), respectively. Preventing accumulation of reducing equivalents at complexes I and III may be especially important to decrease cytotoxic ROS production during the period of ischemia when low amounts of residual oxygen (68) are still present.
|
POSSIBLE CARDIOPROTECTION BY MILD PROTON LEAK |
|---|
|
TOPABSTRACTMITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
|
INCREASED INJURY IN THE AGED HEART DURING ISCHEMIA AND REPERFUSION: REVERSAL BY RESTORATION OF MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION BEFORE ISCHEMIA |
|---|
|
TOPABSTRACTMITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
In the aged heart, ischemic damage to mitochondria is superimposed upon aging-induced defects in mitochondrial oxidative metabolism (83, 84, 86, 100). We evaluated whether an intervention with the potential to improve mitochondrial function in the aged heart before ischemia could decrease myocardial injury during subsequent ischemia and reperfusion. Aging decreases oxidative function only in IFM, whereas SSM are unaffected (46). Treatment with acetylcarnitine was reported (109) to restore aging-induced decreases in cytochrome oxidase activity in the heart. We applied acetylcarnitine treatment to test whether aging-induced decreases in mitochondrial respiration could be improved.
Treatment of aged rats with acetylcarnitine increased the maximal rate of oxidative phosphorylation in IFM to rates observed in the adult heart (85). Respiration in acetylcarnitine-treated aged hearts remained well coupled (85). Adult and aged hearts next underwent 25 min of ischemia, followed by 30 min of reperfusion. In the aged heart, acetylcarnitine improved functional recovery, which was similar to the recovery of treated or untreated adult hearts (85). Acetylcarnitine markedly reduced the release of lactate dehydrogenase in the aged heart, indicating less myocyte necrosis. When the aged heart sustained ischemia and reperfusion following restoration of mitochondrial function, there was less myocardial damage and improved contractile recovery. In contrast, acetylcarnitine treatment had no effect upon the extent of myocardial damage or contractile recovery in the adult heart. These observations provide strong support for the contribution of aging-related defects in mitochondrial metabolism to the enhanced cardiac damage observed following ischemia and reperfusion.
Acetylcarnitine could improve aging defects in electron transport by two mechanisms. First, acetylcarnitine was proposed to increase the content of cardiolipin (109), required for optimal activity of cytochrome oxidase (119, 144). However, aging did not decrease the content of cardiolipin in the aged Fischer 344 rat heart (101). Second, treatment with acetylcarnitine increases transcription of mitochondrial DNA in the aged heart leading to increased mitochondrial protein synthesis and an increased content of mitochondrial-encoded electron transport subunits (49). Regardless of the mechanism, the option to modulate mitochondrial oxidative metabolism by treating age-related, rather than ischemia-induced, damage in a preemptive fashion represents a novel cardioprotective strategy for the aged heart.
Our working model for increased injury in the aged heart is that addition of ischemia-induced defects upon preexisting aging defects would enhance mitochondrial-derived myocyte injury in the aged heart (86). Consistent with previous observations in the adult heart, mitochondrial damage occurred mainly during ischemia, rather than during reperfusion, in the aged heart (86). The contribution of the ETC to damage during ischemia in the aged heart was tested by using rotenone to block electron flow. Rotenone treatment of aged hearts immediately before the onset of ischemia attenuated ischemic damage to IFM (86). Thus, as in the adult heart, the ETC contributes to mitochondrial damage during ischemia in the aged heart. Amobarbital treatment immediately before ischemia (26) protects oxidative phosphorylation in the aged heart following reperfusion (C. Tanaka-Esposito, Q. Chen, and E. J. Lesnefsky, unpublished observations). Thus reversible blockade of electron transport can attenuate the ischemic component of mitochondrial damage in the aged as well as in the adult rat heart.
These studies demonstrate the potential to independently modulate both the age-related and ischemia-induced components of mitochondrial oxidative metabolism that contribute to injury to the aged heart by directly targeting the mitochondrion. Relief of aging-related defects in oxidative metabolism can decrease ischemic myocardial injury in the aged heart (85). In addition, blockade of electron transport attenuates the ischemic mitochondrial damage in the adult and senescent hearts. Future work will uncover the potential interactive benefit of these complimentary approaches to reduce synergistically injury to the aged heart during ischemia and reperfusion.
In summary, the blockade of electron transport or the partial uncoupling of respiration lessens cardiac injury during ischemia and during early reperfusion. Although the concept that disrupting effective oxidative metabolism to protect the heart initially appears counterintuitive, both of these interventions decrease the accumulation of reducing equivalents at key centers in the electron transport chain, namely complex I and complex III, under conditions that favor ROS generation. The protection achieved is mediated via the decreased production and release of ROS from mitochondria, less mitochondrial calcium overload, and the improved retention of cytochrome c by mitochondria. Future work is required to clarify whether decreased calcium overload and cytochrome c release occur as consequences of decreased oxidative injury. It increasingly appears that the cardioprotective paradigms of IPC and postconditioning at least in part modulate mitochondrial oxidative metabolism as effector mechanisms. The initially paradoxical approach to limit mitochondrial oxidative phosphorylation in pathological settings in fact provides a new cardioprotective paradigm. The restriction of mitochondrial oxidative metabolism by therapeutic intervention or via the activation of signaling cascades is a key mechanism of cardiac protection during ischemia and reperfusion. This conceptual approach should continue to foster the evolution of mitochondrial-based treatments to limit cardiac injury during ischemia as well as during reperfusion.
|
GRANTS |
|---|
|
TOPABSTRACTMITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
|
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|
REFERENCES |
|---|
|
TOPABSTRACTMITOCHONDRIA AS TARGETS OF...MITOCHONDRIA AS SOURCES OF...BLOCKADE OF ELECTRON TRANSPORT...IMPROVED MITOCHONDRIAL FUNCTION...MODULATION OF MITOCHONDRIAL...IPC MODULATES MITOCHONDRIAL...POSSIBLE CARDIOPROTECTION BY...INCREASED INJURY IN THE...GRANTSREFERENCES |
|---|
2. Aldakkak M, Heisner JS, Stowe DF, Chen Q, Lesnefsky EJ, Heinen A, Rhodes SS, Camara AK. Inhibition of mitochondrial complex I during ischemia protects hearts, preserves mitochondrial NADH, and reduces mitochondrial Ca2+ overload and ROS production (Abstract). Circulation 112: II-286, 2005.
3. Aldakkak M, Stowe DF, Heisner JS, Stowe DF, Lesnefsky EJ, Chen Q, Heinen A, Rhodes SS, Camara AK. Amobarbital, high K+ and lidocaine protect hearts against ischemia reperfusion injury by differential changes in mitochondrial bioenergetics (Abstract). FASEB J 20: A319, 2006.
4. Ambrosio G, Zweier JL, Duilio C, Kuppusamy P, Santoro G, Elia PP, Tritto I, Cirillo P, Condorelli M, Chiariello M. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem 268: 18532–18541, 1993.
5. An J, Camara AK, Rhodes SS, Riess ML, Stowe DF. Warm ischemic preconditioning improves mitochondrial redox balance during and after mild hypothermic ischemia in guinea pig isolated hearts. Am J Physiol Heart Circ Physiol 288: H2620–H2627, 2005.
6. An J, Camara AK, Riess ML, Rhodes SS, Varadarajan SG, Stowe DF. Improved mitochondrial bioenergetics by anesthetic preconditioning during and after 2 hours of 27°C ischemia in isolated hearts. J Cardiovasc Pharmacol 46: 280–287, 2005.[CrossRef][Web of Science][Medline]
7. An JZ, Rhodes SS, Jiang MT, Bosnjak ZJ, Stowe DF. Anesthetic preconditioning enhances calcium handling and metabolic and mechanical function elicited by Na+/Ca2+ exchange inhibition in isolated hearts. Anesthesiology. 105: 541–549, 2006.[CrossRef][Web of Science][Medline]
8. Anthony G, Reimann A, Kadenbach B. Tissue-specific regulation of bovine heart cytochrome-c oxidase activity by ADP via interaction with subunit VIa. Proc Natl Acad Sci USA 90: 1652–1656, 1993.
9. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 111: 194–197, 2005.
10. Asimakis GK, Conti VR. Myocardial ischemia: correlation of mitochondrial adenine nucleotide and respiratory function. J Mol Cell Cardiol 16: 439–447, 1984.[CrossRef][Web of Science][Medline]
11. Ataka K, Chen D, Levitsky S, Jimenez E, Feinberg H. Effect of aging on intracellular Ca2+, pHi, and contractility during ischemia and reperfusion. Circulation 86: 371–376, 1992.
12. Azhar G, Gao W, Liu L, Wei JY. Ischemia-reperfusion in the adult mouse heart influence of age. Exp Gerontol 34: 699–714, 1999.[CrossRef][Web of Science][Medline]
13. Babcock GT, Varotsis C. Discrete steps in dioxygen activation–the cytochrome oxidase/O2 reaction. J Bioenerg Biomembr 25: 71–80, 1993.[CrossRef][Web of Science][Medline]
14. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61: 461–470, 2004.
15. Becker LB, vanden Hoek TL, Shao ZH, Li CQ, Schumacker PT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol Heart Circ Physiol 277: H2240–H2246, 1999.
16. Bolli R, McCay PB. Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion: a new approach to assessing the role of oxygen radicals in myocardial "stunning". Free Radic Res Commun 9: 169–180, 1990.[Web of Science][Medline]
17. Bopassa JC, Ferrera R, Gateau-Roesch O, Couture-Lepetit E, Ovize M. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 69: 178–185, 2006.
18. Borutaite V, Brown GC. Mitochondria in apoptosis of ischemic heart. FEBS Lett 541: 1–5, 2003.[CrossRef][Web of Science][Medline]
19. Borutaite V, Budriunaite A, Brown GC. Reversal of nitric oxide-, peroxynitrite- and S-nitrosothiol-induced inhibition of mitochondrial respiration or complex I activity by light and thiols. Biochim Biophys Acta 1459: 405–412, 2000.[Medline]
20. Borutaite V, Budriunaite A, Morkuniene R, Brown GC. Release of mitochondrial cytochrome c and activation of cytosolic caspases induced by myocardial ischaemia. Biochim Biophys Acta 1537: 101–109, 2001.[Medline]
21. Borutaite V, Jekabsone A, Morkuniene R, Brown GC. Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. J Mol Cell Cardiol 35: 357–366, 2003.[CrossRef][Web of Science][Medline]
22. Burwell LS, Nadtochiy SM, Tompkins AJ, Young S, Brookes PS. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J 394: 627–634, 2006.[CrossRef][Web of Science][Medline]
23. Camara AKS, Riess ML, Kevin LG, Novallja E, Stowe DF. Hypothermia augments reactive oxygen species detected in the guinea pig isolated perfused heart. Am J Physiol Heart Circ Physiol 286: H1289–H1299, 2004.
24. Chance B, Williams GR, Hollunger G. Inhibition of electron and energy transfer in mitochondria. I. Effects of Amytal, thiopental, rotenone, progesterone, and methylene glycol. J Biol Chem 238: 418–431, 1963.
25. Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J Biol Chem 276: 30724–30728, 2001.
26. Chen Q, Hoppel CL, Lesnefsky EJ. Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria. J Pharmacol Exp Ther 316: 200–207, 2006.
27. Chen Q, Hoppel CL, Lesnefsky EJ. Reperfusion with preserved mitochondrial function decreases mitochondrial hydrogen peroxide production and infarct size (Abstract). FASEB J 20: A318, 2006.
28. Chen Q, Hoppel CL, Lesnefsky EJ. Reversible blockade of electron transport during ischemia protects myocardium by preserving mitochondrial function (Abstract). Circ Res 97: e937-e938, 2005.[CrossRef]
29. Chen Q, Lesnefsky EJ. Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. Free Radic Biol Med 40: 976–982, 2006.[CrossRef][Web of Science][Medline]
30. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278: 36027–36031, 2003.
31. Chen R, Fearnley IM, Peak-Chew SY, Walker JE. The phosphorylation of subunits of complex I from bovine heart mitochondria. J Biol Chem 279: 26036–26045, 2004.
32. Chen YR, Chen CL, Zhang L, Green-Church KB, Zweier JL. Superoxide generation from mitochondrial NADH dehydrogenase induces self-inactivation with specific protein radical formation. J Biol Chem 280: 37339–37348, 2005.
33. Cortese JD, Voglino AL, Hackenbrock CR. The ionic strength of the intermembrane space of intact mitochondria is not affected by the pH or volume of the intermembrane space. Biochim Biophys Acta 1100: 189–197, 1992.[CrossRef][Medline]
34. Costa AD, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV, Critz SD. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97: 329–336, 2005.
35. Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 529: 11–21, 2000.
36. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233–249, 1999.
37. Crompton M, Andreeva L. On the involvement of a mitochondrial pore in reperfusion injury. Basic Res Cardiol 88: 513–523, 1993.[CrossRef][Web of Science][Medline]
38. Da Silva MM, Sartori A, Belisle E, Kowaltowski AJ. Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release, and enhances K+ transport. Am J Physiol Heart Circ Physiol 285: H154–H162, 2003.
39. Davies MJ. Direct detection of radical production in the ischaemic and reperfused myocardium: current status. Free Radic Res Commun 7: 275–284, 1989.[Web of Science][Medline]
40. Degli Esposti M. Inhibitors of NADH-ubiquinone reductase: an overview. Biochim Biophys Acta 1364: 222–235, 1998.[Medline]
41. Demin OV, Kholodenko BN, Skulachev VP. A model of O2·– generation in the complex III of the electron transport chain. Mol Cell Biochem 184: 21–33, 1998.[CrossRef][Web of Science][Medline]
42. Demin OV, Westerhoff HV, Kholodenko BN. Mathematical modeling of superoxide generation with the bc1 complex of mitochondria. Biochemistry (Mosc) 63: 634–649, 1998.[Medline]
43. Di Lisa F, Bernardi P. Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition. Cardiovasc Res 66: 222–232, 2005.
44. Dos Santos P, Kowaltowski AJ, Laclau MN, Seetharaman S, Paucek P, Boudina S, Thambo JB, Tariosse L, Garlid KD. Mechanisms by which opening the mitochondrial ATP- sensitive K+ channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 283: H284–H295, 2002.
45. Duan J, Karmazyn M. Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion. Can J Physiol Pharmacol 67: 704–709, 1989.[Web of Science][Medline]
46. Fannin SW, Lesnefsky EJ, Slabe TJ, Hassan MO, Hoppel CL. Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch Biochem Biophys 372: 399–407, 1999.[CrossRef][Web of Science][Medline]
47. Flameng W, Andres J, Ferdinande P, Mattheussen M, Van Belle H. Mitochondrial function in myocardial stunning. J Mol Cell Cardiol 23: 1–11, 1991.[Web of Science][Medline]
48. Frolkis VV, Frolkis RA, Mkhitarian LS, Fraifeld VE. Age-dependent effects of ischemia and reperfusion on cardiac function and Ca2+ transport in myocardium. Gerontology 37: 233–239, 1991.[Web of Science][Medline]
49. Gadaleta MN, Petruzzella V, Daddabbo L, Olivieri C, Fracasso F, Loguercio Polosa P, Cantatore P. Mitochondrial DNA transcription and translation in aged rat. Effect of acetyl-L-carnitine. Ann NY Acad Sci 717: 150–160, 1994.[Web of Science][Medline]
50. Gadd ME, Broekemeier KM, Crouser ED, Kumar J, Graff G, Pfeiffer DR. Mitochondrial iPLA2 activity modulates the release of cytochrome c from mitochondria and influences the permeability transition. J Biol Chem 281: 6931–6939, 2006.
51. Ganote CE, McGarr J, Liu SY, Kaltenbach JP. Oxygen-induced enzyme release. Assessment of mitochondrial function in anoxic myocardial injury and effects of the mitochondrial uncoupling agent 2,4-dinitrophenol (DNP). J Mol Cell Cardiol 12: 387–408, 1980.[CrossRef][Web of Science][Medline]
52. Ganote CE, Worstell J, Kaltenbach JP. Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts. Am J Pathol 84: 327–350, 1976.[Abstract]
53. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621–1628, 1994.[Web of Science][Medline]
54. Griffiths EJ, Halestrap AP. Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 25: 1461–1469, 1993.[CrossRef][Web of Science][Medline]
55. Grover GJ, Dzwonczyk S, Sleph PG. Ruthenium red improves postischemic contractile function in isolated rat hearts. J Cardiovasc Pharmacol 16: 783–789, 1990.[Web of Science][Medline]
56. Grover GJ, Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32: 677–695, 2000.[CrossRef][Web of Science][Medline]
57. Gunter TE, Pfeiffer DR. Mechanisms by which mitochondria transport calcium. Am J Physiol Cell Physiol 258: C755–C786, 1990.
58. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion–a target for cardioprotection. Cardiovasc Res 61: 372–385, 2004.
59. Han D, Antunes F, Canali R, Rettori D, Cadenas E. Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. J Biol Chem 278: 5557–5563, 2003.
60. Han J, Kim N, Kim E, Ho WK, Earm YE. Modulation of ATP-sensitive potassium channels by cGMP-dependent protein kinase in rabbit ventricular myocytes. J Biol Chem 276: 22140–22147, 2001.
61. Hatefi Y. Flavoproteins of the electron transport system and the site of action of Amytal, rotenone, and piericidin A. Proc Natl Acad Sci USA 60: 733–740, 1968.
62. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15: 69–75, 2005.[CrossRef][Web of Science][Medline]
63. Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35: 339–341, 2003.[CrossRef][Web of Science][Medline]
64. Heinen A, Camara A, Aldakkak M, Rhodes SS, Riess ML, Stowe DF. Mitochondrial Ca2+-induced K+ influx increases respiration and enhances ROS production while maintaining membrane potential. Am J Physiol Cell Physiol. In Press.
65. Hoch FL. Cardiolipins and biomembrane function. Biochim Biophys Acta 1113: 71–133, 1992.[Medline]
66. Holmuhamedov EL, Jahangir A, Oberlin A, Komarov A, Colombini M, Terzic A. Potassium channel openers are uncoupling protonophores: implication in cardioprotection. FEBS Lett 568: 167–170, 2004.[CrossRef][Web of Science][Medline]
67. Horgan DJ, Singer TP, Casida JE. Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. 13 Binding sites of rotenone, piericidin A, and amytal in the respiratory chain. J Biol Chem 243: 834–843, 1968.
68. Ilangovan G, Liebgott T, Kutala VK, Petryakov S, Zweier JL, Kuppusamy P. EPR oximetry in the beating heart: myocardial oxygen consumption rate as an index of postischemic recovery. Magn Reson Med 51: 835–842, 2004.[CrossRef][Web of Science][Medline]
69. Kajiyama K, Pauly DF, Hughes H, Yoon SB, Entman ML, and McMillin-Wood JB. Protection by verapamil of mitochondrial glutathione equilibrium and phospholipid changes during reperfusion of ischemic canine myocardium. Circ Res 61: 301–310, 1987.
70. Kawata H, Yoshida K, Kawamoto A, Kurioka H, Takase E, Sasaki Y, Hatanaka K, Kobayashi M, Ueyama T, Hashimoto T, Dohi K. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res 88: 696–704, 2001.
71. Kevin LG, Camara AK, Riess ML, Novalija E, Stowe DF. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol 284: H566–H574, 2003.
72. Khaliulin I, Schwalb H, Wang P, Houminer E, Grinberg L, Katzeff H, Borman JB, Powell SR. Preconditioning improves postischemic mitochondrial function and diminishes oxidation of mitochondrial proteins. Free Radic Biol Med 37: 1–9, 2004.[Web of Science][Medline]
73. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 7: 1166–1173, 2000.[CrossRef][Web of Science][Medline]
74. Kowaltowski AJ, Seetharaman S, Paucek P, Garlid KD. Bioenergetic consequences of opening the ATP-sensitive K+ channel of heart mitochondria. Am J Physiol Heart Circ Physiol 280: H649–H657, 2001.
75. Kushnareva Y, Murphy AN, Andreyev A. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem J 368: 545–553, 2002.[CrossRef][Web of Science][Medline]
76. Lambert AJ, Brand MD. Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). J Biol Chem 15: 15, 2004.
77. Lee JW, Bobst EV, Wang YG, Ashraf MM, Bobst AM. Increased endogenous ascorbyl free radical formation with singlet oxygen scavengers in reperfusion injury: an EPR and functional recovery study in rat hearts. Cell Mol Biol (Noisy-le-grand) 46: 1383–1395, 2000.[Medline]
78. Lee TM, Su SF, Chou TF, Lee YT, Tsai CH. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 105: 334–340, 2002.
79. Lemasters JJ, Nieminen AL. Mitochondrial oxygen radical formation during reductive and oxidative stress to intact hepatocytes. Biosci Rep 17: 281–291, 1997.[CrossRef][Web of Science][Medline]
80. Lesnefsky EJ, Chen Q, Moghaddas S, Hassan MO, Tandler B, Hoppel CL. Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem 279: 47961–47967, 2004.
81. Lesnefsky EJ, Chen Q, Slabe TJ, Stoll MS, Minkler PE, Hassan MO, Tandler B, Hoppel CL. Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. Am J Physiol Heart Circ Physiol 287: H258–H267, 2004.
82. Lesnefsky EJ, Gallo DS, Ye J, Whittingham TS, Lust WD. Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heart. J Lab Clin Med 124: 843–851, 1994.[Web of Science][Medline]
83. Lesnefsky EJ, Gudz TI, Migita CT, Ikeda-Saito M, Hassan MO, Turkaly PJ, Hoppel CL. Ischemic injury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys 385: 117–128, 2001.[CrossRef][Web of Science][Medline]
84. Lesnefsky EJ, Gudz TI, Moghaddas S, Migita CT, Ikeda-Saito M, Turkaly PJ, Hoppel CL. Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site. J Mol Cell Cardiol 33: 37–47, 2001.[CrossRef][Web of Science][Medline]
85. Lesnefsky EJ, He D, Moghaddas S, Hoppel CL. Reversal of mitochondrial defects before ischemia protects the aged heart. FASEB J 20: 1543–1545, 2006.
86. Lesnefsky EJ, Hoppel CL. Ischemia-reperfusion injury in the aged heart: role of mitochondria. Arch Biochem Biophys 420: 287–297, 2003.[CrossRef][Web of Science][Medline]
87. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol 33: 1065–1089, 2001.[CrossRef][Web of Science][Medline]
88. Lesnefsky EJ, Moghaddas S, Vazquez E, Hoppel C. Mitochondrial-derived mitochondrial damage occurs during ischemia in the senescent heart (Abstract). FASEB J: A518, 2003.
89. Lesnefsky EJ, Slabe TJ, Stoll MS, Minkler PE, Hoppel CL. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 280: H2770–H2778, 2001.
90. Lesnefsky EJ, Tandler B, Ye J, Slabe TJ, Turkaly J, Hoppel CL. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 273: H1544–H1554, 1997.
91. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278: 8516–8525, 2003.
92. Liu L, Azhar G, Gao W, Zhang X, Wei JY. Bcl-2 and Bax expression in adult rat hearts after coronary occlusion: age-associated differences. Am J Physiol Regul Integr Comp Physiol 275: R315–R322, 1998.
93. Lucas DT, Szweda LI. Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. Proc Natl Acad Sci USA 95: 510–514, 1998.
94. Lucas DT, Szweda LI. Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proc Natl Acad Sci USA 96: 6689–6693, 1999.
95. Lundberg KC, Szweda LI. Preconditioning prevents loss in mitochondrial function and release of cytochrome c during prolonged cardiac ischemia/reperfusion. Arch Biochem Biophys 453: 128–132, 2006.[CrossRef]
96. Maupoil V, Rochette L, Tabard A, Clauser P, Harpey C. Evolution of free radical formation during low-flow ischemia and reperfusion in isolated rat heart. Cardiovasc Drugs Ther 4: 791–795, 1990.
97. Merrill GF. Acetaminophen and low-flow myocardial ischemia: efficacy and antioxidant mechanisms. Am J Physiol Heart Circ Physiol 282: H1341–H1349, 2002.
98. Minners J, van den Bos EJ, Yellon DM, Schwalb H, Opie LH, Sack MN. Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res 47: 68–73, 2000.
99. Miwa S, Brand MD. Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling. Biochem Soc Trans 31: 1300–1301, 2003.[Web of Science][Medline]
100. Moghaddas S, Hoppel CL, Lesnefsky EJ. Aging defect at the Qo site of complex III augments oxyradical production in rat heart interfibrillar mitochondria. Arch Biochem Biophys 414: 59–66, 2003.[CrossRef][Web of Science][Medline]
101. Moghaddas S, Stoll MS, Minkler PE, Salomon RG, Hoppel CL, Lesnefsky EJ. Preservation of cardiolipin content during aging in rat heart interfibrillar mitochondria. J Gerontol A Biol Sci Med Sci 57: B22-B28, 2002.
102. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124–1136, 1986.
103. Nadtochiy SM, Tompkins AJ, Brookes PS. Different mechanisms of mitochondrial proton leak in ischaemia/reperfusion injury and preconditioning: implications for pathology and cardioprotection. Biochem J 395: 611–618, 2006.[CrossRef][Web of Science][Medline]
104. Nohl H. Generation of superoxide radicals as byproduct of cellular respiration. Ann Biol Clin (Paris) 52: 199–204, 1994.[Medline]
105. O'Rourke B. Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res 94: 420–432, 2004.
106. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA 99: 1259–1263, 2002.
107. Palmer JW, Tandler B, Hoppel CL. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 252: 8731–8739, 1977.
108. Palmer JW, Tandler B, Hoppel CL. Heterogeneous response of subsarcolemmal heart mitochondria to calcium. Am J Physiol Heart Circ Physiol 250: H741–H748, 1986.
109. Paradies G, Ruggiero FM, Dinoi P, Petrosillo G, Quagliariello E. Age-dependent decrease in the cytochrome c oxidase activity and changes in phospholipids in rat-heart mitochondria. Arch Gerontol Geriatr 16: 262–272, 1993.
110. Park JW, Chun YS, Kim YH, Kim CH, Kim MS. Ischemic preconditioning reduces O2– generation and prevents respiratory impairment in the mitochondria of post-ischemic reperfused heart of rat. Life Sci 60: 2207–2219, 1997.[CrossRef][Web of Science][Medline]
111. Petrosillo G, Di Venosa N, Ruggiero FM, Pistolese M, D'Agostino D, Tiravanti E, Fiore T, Paradies G. Mitochondrial dysfunction associated with cardiac ischemia/reperfusion can be attenuated by oxygen tension control. Role of oxygen-free radicals and cardiolipin. Biochim Biophys Acta 1710: 78–86, 2005.[Medline]
112. Pietri S, Culcasi M, Cozzone PJ. Real-time continuous-flow spin trapping of hydroxyl free radical in the ischemic and post-ischemic myocardium. Eur J Biochem 186: 163–173, 1989.[Web of Science][Medline]
113. Piper HM, Sezer O, Schleyer M, Schwartz P, Hutter JF, Spieckermann PG. Development of ischemia-induced damage in defined mitochondrial subpopulations. J Mol Cell Cardiol 17: 885–896, 1985.[CrossRef][Web of Science][Medline]
114. Qian T, Nieminen AL, Herman B, Lemasters JJ. Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol Cell Physiol 273: C1783–C1792, 1997.
115. Riess ML, Camara AK, Chen Q, Novalija E, Rhodes SS, Stowe DF. Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts. Am J Physiol Heart Circ Physiol 283: H53–H60, 2002.
116. Riess ML, Camara AK, Kevin LG, An J, Stowe DF. Reduced reactive O2 species formation and preserved mitochondrial NADH and [Ca2+] levels during short-term 17°C ischemia in intact hearts. Cardiovasc Res 61: 580–590, 2004.
117. Riess ML, Camara AK, Novalija E, Chen Q, Rhodes SS, Stowe DF. Anesthetic preconditioning attenuates mitochondrial Ca2+ overload during ischemia in guinea pig intact hearts: reversal by 5-hydroxydecanoic acid. Anesth Analg 95: 1540–1546, 2002.
118. Riess ML, Novalija E, Camara AK, Eells JT, Chen Q, Stowe DF. Preconditioning with sevoflurane reduces changes in nicotinamide adenine dinucleotide during ischemia-reperfusion in isolated hearts: reversal by 5-hydroxydecanoic acid. Anesthesiology 98: 387–395, 2003.[CrossRef][Web of Science][Medline]
119. Robinson NC, Strey F, Talbert L. Investigation of the essential boundary layer phospholipids of cytochrome c oxidase using Triton X-100 delipidation. Biochemistry 19: 3656–3661, 1980.[CrossRef][Medline]
120. Rouslin W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol Heart Circ Physiol 244: H743–H748, 1983.
121. Rytomaa M, Kinnunen PK. Evidence for two distinct acidic phospholipid-binding sites in cytochrome c. J Biol Chem 269: 1770–1774, 1994.
122. Salamon Z, Tollin G. Interaction of horse heart cytochrome c with lipid bilayer membranes: effects on redox potentials. J Bioenerg Biomembr 29: 211–221, 1997.[CrossRef][Web of Science][Medline]
123. Schilling B, Aggeler R, Schulenberg B, Murray J, Row RH, Capaldi RA, Gibson BW. Mass spectrometric identification of a novel phosphorylation site in subunit NDUFA10 of bovine mitochondrial complex I. FEBS Lett 579: 2485–2490, 2005.[CrossRef][Web of Science][Medline]
124. Serviddio G, Di Venosa N, Federici A, D'Agostino D, Rollo T, Prigigallo F, Altomare E, Fiore T, Vendemiale G. Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxide production and glutathione depletion. FASEB J 19: 354–361, 2005.
125. Shidoji Y, Hayashi K, Komura S, Ohishi N, Yagi K. Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochem Biophys Res Commun 264: 343–347, 1999.[CrossRef][Web of Science][Medline]
126. Shin G, Sugiyama M, Shoji T, Kagiyama A, Sato H, Ogura R. Detection of mitochondrial membrane damages in myocardial ischemia with ESR spin labeling technique. J Mol Cell Cardiol 21: 1029–1036, 1989.[CrossRef][Web of Science][Medline]
127. Spiegel HE, Wainio WW. Some features of barbiturate interaction and inhibition of NADH-cytochrome c oxidoreductase in respiring systems. J Pharmacol Exp Ther 165: 23–29, 1969.
128. Spooner PJ, Watts A. Cytochrome c interactions with cardiolipin in bilayers: a multinuclear magic-angle spinning NMR study. Biochemistry 31: 10129–10138, 1992.[CrossRef][Medline]
129. Stowe DF, Aldakkak M, Camara AK, Riess ML, Heinen A, Varadarajan SG, Jiang MT. Cardiac mitochondrial preconditioning by Big Ca2+-sensitive K+ channel opening requires superoxide radical generation. Am J Physiol Heart Circ Physiol 290: H434–H440, 2006.
130. Sun HY, Wang NP, Kerendi F, Halkos M, Kin H, Guyton RA, Vinten-Johansen J, Zhao ZQ. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 288: H1900–H1908, 2005.
131. Takeo S, Nasa Y. Role of energy metabolism in the preconditioned heart–a possible contribution of mitochondria. Cardiovasc Res 43: 32–43, 1999.
132. Tanaka-Esposito CC, Chen Q, Hoppel CL, Lesnefsky EJ. Ischemic preconditioning does not alter NADH supported state 3 respiration or complex I activity (Abstract). FASEB J 20: A319, 2006.
133. Tani M, Honma Y, Hasegawa H, Tamaki K. Direct activation of mitochondrial KATP channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res 49: 56–68, 2001.
134. Tani M, Suganuma Y, Hasegawa H, Shinmura K, Ebihara Y, Hayashi Y, Guo X, Takayama M. Decrease in ischemic tolerance with aging in isolated perfused Fischer 344 rat hearts: relation to increases in intracellular Na+ after ischemia. J Mol Cell Cardiol 29: 3081–3089, 1997.[CrossRef][Web of Science][Medline]
135. Teshima Y, Akao M, Jones SP, Marban E. Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 93: 192–200, 2003.
136. Tong H, Rockman HA, Koch WJ, Steenbergen C, Murphy E. G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning. Circ Res 94: 1133–1141, 2004.
137. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 552: 335–344, 2003.
138. Turrens JF, Beconi M, Barilla J, Chavez UB, McCord JM. Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radic Res Commun 12–13: 681–689, 1991.
139. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 191: 421–427, 1980.[Web of Science][Medline]
140. Ueta H, Ogura R, Sugiyama M, Kagiyama A, Shin G. O2- spin trapping on cardiac submitochondrial particles isolated from ischemic and non-ischemic myocardium. J Mol Cell Cardiol 22: 893–899, 1990.[CrossRef][Web of Science][Medline]
141. Vanden Hoek T, Becker LB, Shao ZH, Li CQ, Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 86: 541–548, 2000.
142. Vanden Hoek TL, Li C, Shao Z, Schumacker PT, Becker LB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 29: 2571–2583, 1997.[CrossRef][Web of Science][Medline]
143. Veitch K, Hombroeckx A, Caucheteux D, Pouleur H, Hue L. Global ischaemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischaemic damag. Biochem J 281: 709–715, 1992.
144. Vik SB, Capaldi RA. Lipid requirements for cytochrome c oxidase activity. Biochemistry 16: 5755–5759, 1977.[CrossRef][Medline]
145. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 93: 292–301, 2003.
146. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vasquez-Vivar J, Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 34: 1359–1368, 2003.[CrossRef][Web of Science][Medline]
147. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579–H588, 2003.
This article has been cited by other articles:
|
|
 |
|
  C. Dezfulian, S. Shiva, A. Alekseyenko, A. Pendyal, D.G. Beiser, J. P. Munasinghe, S. A. Anderson, C. F. Chesley, T.L. Vanden Hoek, and M. T. Gladwin Nitrite Therapy After Cardiac Arrest Reduces Reactive Oxygen Species Generation, Improves Cardiac and Neurological Function, and Enhances Survival via Reversible Inhibition of Mitochondrial Complex I Circulation, September 8, 2009; 120(10): 897 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schwarzer and T. Doenst Letter to the editor: "Does a reduction in ADP-limited respiration indicate impaired mitochondrial function?" Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H889 - H889. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Frassdorf, S. De Hert, and W. Schlack Anaesthesia and myocardial ischaemia/reperfusion injury Br. J. Anaesth., July 1, 2009; 103(1): 89 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pasdois, B. Beauvoit, L. Tariosse, B. Vinassa, S. Bonoron-Adele, and P. D. Santos Effect of diazoxide on flavoprotein oxidation and reactive oxygen species generation during ischemia-reperfusion: a study on Langendorff-perfused rat hearts using optic fibers Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2088 - H2097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Chen, S. Moghaddas, C. L. Hoppel, and E. J. Lesnefsky Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria Am J Physiol Cell Physiol, February 1, 2008; 294(2): C460 - C466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aldakkak, D. F. Stowe, Q. Chen, E. J. Lesnefsky, and A. K.S. Camara Inhibited mitochondrial respiration by amobarbital during cardiac ischaemia improves redox state and reduces matrix Ca2+ overload and ROS release Cardiovasc Res, January 15, 2008; 77(2): 406 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jahangir, S. Sagar, and A. Terzic Aging and cardioprotection J Appl Physiol, December 1, 2007; 103(6): 2120 - 2128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Heinen, M. Aldakkak, D. F. Stowe, S. S. Rhodes, M. L. Riess, S. G. Varadarajan, and A. K. S. Camara Reverse electron flow-induced ROS production is attenuated by activation of mitochondrial Ca2+-sensitive K+ channels Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1400 - H1407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Westberg, M. Serlachius, P. Lankila, and L. C. Andersson Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1766 - H1771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tanaka-Esposito, Q. Chen, S. Moghaddas, and E. J. Lesnefsky Ischemic preconditioning does not protect via blockade of electron transport J Appl Physiol, August 1, 2007; 103(2): 623 - 628. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
